Table 1 Clinical characteristics of Cohort II
Characteristics | Cohort II: N (%) |
|---|---|
Age: median (range) | 54 (37–83) |
Stage: | |
 III | 76 (89.6) |
 IV | 9 (10.6) |
Residual tumor: | |
 R0 | 42 (49.4) |
 R1 | 37 (43.5) |
 R2 | 6 (7.1) |
Pt-chemo response | |
 Sensitive | 64 (75.3) |
 Resistant | 21 (24.7) |
BRCA status: | |
 Intact | 57 (67.1) |
 Deficient | 23 (27.1) |
 Monoallelic pathogenic | 5 (5.8) |